Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
Condition:   Pediatric Gastroesophageal Reflux DiseaseIntervention:   Drug: DexlansoprazoleSponsor:   TakedaNot yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2015 Category: Research Source Type: clinical trials

Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease
Condition:   Gastroesophageal Reflux DiseaseInterventions:   Drug: Dexlansoprazole 30 mg;   Drug: Dexlansoprazole 60 mgSponsor:   TakedaRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2015 Category: Research Source Type: clinical trials